Empagliflozin vs Irbesartan

## Empagliflozin vs Irbesartan: Overview

This comparison examines the pharmacological differences between **Empagliflozin** and **Irbesartan**.

## Mechanism of Action

**Empagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

**Irbesartan**: Selective non-competitive angiotensin II type 1 receptor antagonist.

## Pharmacokinetics

**Half-life**: Empagliflozin — 12.4 hours; Irbesartan — 11-15 hours.

## Chemical Properties

**Molecular Formula**: Empagliflozin — C23H27ClO7; Irbesartan — C25H28N6O.

**Molecular Weight**: Empagliflozin — 450.9100 g/mol; Irbesartan — 428.5320 g/mol.

**Type**: Empagliflozin — Small molecule; Irbesartan — Small molecule.